-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Axsome Therapeutics, Raises Price Target to $268

Benzinga·08/11/2026 10:24:10
Listen to the news
Needham analyst Ami Fadia maintains Axsome Therapeutics (NASDAQ:AXSM) with a Buy and raises the price target from $267 to $268.